WHO urges countries to increase screening and treatment for hepatitis – BusinessGhana News



[ad_1]

The World Health Organization (WHO) and its partners have called on countries to urgently increase screening and treatment services for hepatitis in order to eradicate the disease. viral hepatitis as a threat to public health by 2030.

which fell on Saturday, and focused on the theme "Test.Treat Hepatitis"

Dr. Tedros Adhanom Ghebreyesus, Director General from the WHO, said in a video statement: "We have a clear vision of elimination, and we have the tools to do it.But we need to accelerate progress to reach our goal of & # de de pour pour pour pour Eliminate hepatitis by 2030. "

He stated that viral hepatitis B and C affected 325 million people worldwide. Untreated, these infections lead to liver cancer and cirrhosis, which caused more than 1.3 million deaths in 2015.

Worldwide, less than 20% of people had access to screening and of Hepatitis B and C infections treatment at the end of 2016.

On the occasion of World Hepatitis Day 2018, WHO organizes several events with the Government of Mongolia, a country heavily affected by hepatitis, but also champion of the world fight.

More than 10% of the three million Mongolians live with chronic hepatitis. The country has launched its National Healthy Liver Program in 2017, with ambitious targets for 2020.

Aiming to accelerate global progress, WHO is also publishing new global guidelines on the treatment of bad cancer. Hepatitis C. The guidelines allow for major simplifications in the provision of curative therapy to the 70 million people living with chronic hepatitis C worldwide. "The elimination of hepatitis will require continued innovation, better medicines and better health services," said Dr. Gottfried Hirnschall. WHO Director for HIV and Hepatitis

"Our new recommendations should allow all those who have hepatitis C to have access to tests and curative treatments right now. "

The WHO and global partners share the experiences of countries like Mongolia.

Renewed action and investments in viral hepatitis are needed to achieve a world where transmission is interrupted and where anyone living with viral hepatitis has access to safe care and treatment, affordable and effective

[ad_2]
Source link